0.18 CNY
15.39 M CNY
655.52 M CNY
157.40 M
About TIBET AIM PHARM IN
Sector
CEO
Min Zhou
Headquarters
Chengdu
Website
Founded
2007
ISIN
CNE100002C39
FIGI
BBG00C9R5XT5
Tibet Aim Pharm., Inc. engages in the research and development, production, and sale of chemical drugs, and Chinese medicines. Its products include miglitol tablets, gualoupi injections, nalmefene hydrochloride injections, carbetocin injections, hongjin xiaojie tablets, and aceclofenac enteric-coated tablets. The company was founded on December 29, 2007 and is headquartered in Chengdu, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 002826 is 11.47 CNY — it has decreased by −1.87% in the past 24 hours. Watch TIBET AIM PHARM IN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange TIBET AIM PHARM IN stocks are traded under the ticker 002826.
002826 stock has fallen by −0.09% compared to the previous week, the month change is a 17.68% rise, over the last year TIBET AIM PHARM IN has showed a −9.26% decrease.
002826 reached its all-time high on Feb 28, 2017 with the price of 35.60 CNY, and its all-time low was 5.57 CNY and was reached on Feb 8, 2024. View more price dynamics on 002826 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002826 stock is 6.22% volatile and has beta coefficient of 1.37. Track TIBET AIM PHARM IN stock price on the chart and check out the list of the most volatile stocks — is TIBET AIM PHARM IN there?
Today TIBET AIM PHARM IN has the market capitalization of 2.03 B, it has increased by 3.97% over the last week.
Yes, you can track TIBET AIM PHARM IN financials in yearly and quarterly reports right on TradingView.
002826 net income for the last quarter is 2.17 M CNY, while the quarter before that showed 11.75 M CNY of net income which accounts for −81.50% change. Track more TIBET AIM PHARM IN financial stats to get the full picture.
Yes, 002826 dividends are paid annually. The last dividend per share was 0.03 CNY. As of today, Dividend Yield (TTM)% is 0.27%. Tracking TIBET AIM PHARM IN dividends might help you take more informed decisions.
TIBET AIM PHARM IN dividend yield was 0.25% in 2023, and payout ratio reached 37.17%. The year before the numbers were 0.98% and 43.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 25, 2024, the company has 439.00 employees. See our rating of the largest employees — is TIBET AIM PHARM IN on this list?
Like other stocks, 002826 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIBET AIM PHARM IN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIBET AIM PHARM IN technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIBET AIM PHARM IN stock shows the strong buy signal. See more of TIBET AIM PHARM IN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.